Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain
Andres J. Munoz, Laura Ortega, Ana Gutierrez, Enrique Gallardo, Dario Rubio-Rodriguez, Carlos Rubio-Terres, Blanca Moron, Pilar Garcia-Alfonso, Jose Manuel Soria
JOURNAL OF MEDICAL ECONOMICS (2023)
Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States
November McGarvey, Matthew Gitlin, Ela Fadli, Karen C. Chung
JOURNAL OF MEDICAL ECONOMICS (2023)
The cost-of-illness and burden-of-disease of treatment-resistant depression in Austria
Evelyn Walter, Matthaeus Traunfellner, Martin Gleitsmann, Michaela Zalesak, Christian Helmenstein
JOURNAL OF MEDICAL ECONOMICS (2023)
Improving Access to and Coverage of Rehabilitation Services through the Implementation of Rehabilitation in Primary Health Care: A Case Study from Chile
Vanessa Seijas, Katherina M. Hrzic, Ximena Z. Neculhueque, Carla Sabariego
HEALTH SYSTEMS & REFORM (2023)
The Promise of Grassroots Approaches to Solving Absenteeism in Primary Health-Care Facilities in Nigeria: Evidence from a Qualitative Study
Obinna Onwujekwe, Prince Agwu, Pallavi Roy, Eleanor Hutchinson, Charles Orjiakor, Martin McKee, Aloysius Odii, Chukwudi Nwokolo, Mushtaq Khan, Susannah Mayhew, Dina Balabanova
HEALTH SYSTEMS & REFORM (2023)
A Gender-Based and Quasi-Experimental Study of the Catastrophic and Impoverishing Health-Care Expenditures in Mexican Households with Elderly Members, 2000-2020
Edson Servan-Mori, Emanuel Orozco-Nunez, Carlos M. Guerrero-Lopez, J. Jaime Miranda, Stephen Jan, Laura Downey, Emma Feeny, Ileana Heredia-Pi, Laura Flamand, Gustavo Nigenda, Robyn Norton, Rafael Lozano
HEALTH SYSTEMS & REFORM (2023)
Health care resource utilization patterns among patients with Parkinson's disease psychosis: analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics
Krithika Rajagopalan, Nazia Rashid, Shikhar Kumar, Dilesh Doshi
JOURNAL OF MEDICAL ECONOMICS (2023)
The impact of transparency constraints on the efficiency of the Russian healthcare system: systematic literature review
Yuriy Timofeyev, Oksana Dremova, Mihajlo Jakovljevic
JOURNAL OF MEDICAL ECONOMICS (2023)
Informing a cost-effectiveness threshold for Saudi Arabia
Ahmed Hamdan Al-Jedai, James Lomas, Hajer Yousef Almudaiheem, Yazed Sulaiman H. Al-Ruthia, Shabab Alghamdi, Nancy Awad, Ahlam Alghamdi, Mohammad A. Alowairdhi, Hana Alabdulkarim, Majid Almadi, Reem F. Bunyan, Jessica Ochalek
JOURNAL OF MEDICAL ECONOMICS (2023)
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States
Christopher Raspin, Edward Faught, Jeanne Armand, Francesca Barion, Vicki Pollit, Joanna Murphy, Vanessa Danielson
JOURNAL OF MEDICAL ECONOMICS (2023)
The cost-effectiveness of a nursing home-based transitional care unit for increasing the potential for independent living in the community among hospitalized older adults
Maya Murmann, Danielle Sinden, Amy T. T. Hsu, Kednapa Thavorn, Anan Bader Eddeen, Annie H. H. Sun, Benoit Robert
JOURNAL OF MEDICAL ECONOMICS (2023)
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison
Francisco Cruz, Natalya Danchenko, Kyle Fahrbach, Andreas Freitag, Jialu Tarpey, John Whalen
JOURNAL OF MEDICAL ECONOMICS (2023)
Targeted literature review of the burden of extraintestinal pathogenic Escherichia Coli among elderly patients in Asia Pacific regions
Norio Ohmagari, Won Suk Choi, Hung-Jen Tang, Petar Atanasov, Xiaobin Jiang, Luis Hernandez Pastor, Yoshikazu Nakayama, Jason Chiang, Kyunghwa Lim, Maria Carmen Nievera
JOURNAL OF MEDICAL ECONOMICS (2023)
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020 (vol 26, pg 376, 2023)
N. Kim, A. Aly, C. Craver, W. T. Garvey
JOURNAL OF MEDICAL ECONOMICS (2023)
The Politics of Health Policy Agenda Setting in India: The Case of the PMJAY Program
Anuska Kalita, Kevin Croke
HEALTH SYSTEMS & REFORM (2023)
The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review
Vicki Pierre, Florin Draica, Manuela Di Fusco, Jingyan Yang, Solange Nunez-Gonzalez, Joanna Kamar, Santiago Lopez, Mary M. Moran, Jennifer Nguyen, Piedad Alvarez, Ashley Cha-Silva, Meghan Gavaghan, Alon Yehoshua, Naomi Stapleton, Heather Burnett
JOURNAL OF MEDICAL ECONOMICS (2023)
Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+breast cancer treatment in Saudi Arabia: simulation study
Consuela Cheriece Yousef, Mansoor Ahmed Khan, Hind Almodaimegh, Majed Alshamrani, Meteb Al-Foheidi, Hana AlAbdalkarim, Ahmed AlJedai, Anjum Naeem, Ivo Abraham
JOURNAL OF MEDICAL ECONOMICS (2023)
Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs
Goran Bencina, Nour Chami, Robert Hughes, Georgie Weston, Carl Baxter, Adam Maciejczyk, Lazar Popovic, Eugenia Karamousouli, Stina Salomonsson
JOURNAL OF MEDICAL ECONOMICS (2023)
Advancing towards a worldwide healthcare system in the post-COVID-19 era: benefits and barriers to international collaboration in healthcare
Ahmad Z. Al Meslamani
JOURNAL OF MEDICAL ECONOMICS (2023)
Evaluating process utilities for the treatment burden of chemotherapy in multiple myeloma in Japan: a time trade-off valuation study
Tadao Ishida, Mayuko Nakakoji, Tatsunori Murata, Fujio Matsuyama, Shinsuke Iida
JOURNAL OF MEDICAL ECONOMICS (2023)